Gedea Biotech
Lund, SE · 1 known investors
Gedea Biotech develops pHyph, an antibiotic-free treatment for bacterial vaginosis and other common vaginal infections aimed at supporting a healthy microbiome. A spin-out from Lund University, the company focuses on women's health and is pursuing partnerships and regulatory approvals in Europe and the US.
Founders & leadership
UE
Ulf EllervikCo-founder, board member, responsible for R&D and patents
HS
Helena StrevensCo-founder, board member, medical advisor
SM
Sophie MannerCo-founder
OS
Olov SternerCo-founder
JW
Julie Waras BrogreninCEO
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountEIC Accelerator grantMar 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Gedea Biotech do?
- Gedea Biotech develops pHyph, an antibiotic-free treatment for bacterial vaginosis and other common vaginal infections aimed at supporting a healthy microbiome. A spin-out from Lund University, the company focuses on women's health and is pursuing partnerships and regulatory approvals in Europe and the US.
- Who founded Gedea Biotech?
- Gedea Biotech was founded by Ulf Ellervik, Helena Strevens, Sophie Manner, Olov Sterner.
- Who are Gedea Biotech's investors?
- Gedea Biotech's investors include LU Innovation.
- Where is Gedea Biotech headquartered?
- Gedea Biotech is headquartered in Lund, SE.